Keywords

• SR9011
• 1379686-29-9
• Best quality

Quick Details

• ProName: Best quality low price SR9011
• CasNo: 1379686-29-9
• Molecular Formula: C23H31ClN4O3S
• Appearance: White Powder
• Application: Auxiliaries and Other Medicinal Chemic...
• DeliveryTime: 15-20 days after receive the deposit
• PackAge: Bucket/Bottled/Bags
• Port: TianJin Or QingDao
• ProductionCapacity: 50000 Metric Ton/Month
• Purity: 99%
• Storage: Store at RT.
• Transportation: By express(DHL,TNT,FedEx,UPS,and other...
• LimitNum: 1 Kilogram

Superiority

Our Advantages:

1.We have abundant professional production experience.

2.We have our own chemical factory.

3.Sample is free of charge. 

4. Reasonable Price, Excellent Quality & Attentive Service 

5. Prompt reply: we can reply your inquiry and email within 24 hours.

6.Fast Delivery: The delivery time is about 10-20 days after receiving the deposit.

7. We have a unity cooperation team

Details

Best quality low price SR9011

Product Description

CAS No: 1379686-29-9

Molecular Formular: C23H31ClN4O3S

Molecular Weight: 437.94026

Appearance: White fine powder

Solubility: insoluble in water

SARMs SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration (IC50) = 790 nM for Rev-Erbα and IC50 = 560 nM for Rev-ErbAβ.   

Up to now, no side effects have been observed with SR9011, so it may be seen as an extremely safe compound.  Moreover, just like in the case of other SARMS, SR9009 is not liver toxic, but there is a need for liver supporting supplements when using it.  N2Guard at 3-5 capsules per day will be sufficient liver and kidney support.

Application  

SR 9009 is one of a pair of compounds developed at TSRI by Burris and his team. The drug binds to Rev-erbα, a natural protein in the body that influences lipid and glucose metabolism in the liver, inflammatory responses, and fat-storing cells. By binding to Rev-erbα, SR9009 can kickstart metabolism with another pleasant side-effect: increased muscle strength. Now, after modulating Rev-erbα's activity with drugs, studies have shown its direct effect on skeletal muscles.

With such strong results, Burris and his team are pursuing funding for a biotechnology company that would focus primarily on the development of SR9009 and other similar compounds for safe use in humans. 

Company Overview

      ShanLong Biotechnology Co., Ltd. is a high-tech enterprise specializing in high-tech and high value-added cosmetic raw materials, pharmaceutical intermediates, chemical customization, research and development, production and sales. The company has its own R&D center and production base. Strong technical force, complete product testing methods and quality assurance system. The company not only has a group of high-tech talents engaged in the research and development, production, and management of pharmaceutical intermediates, but also makes full use of the technological and information advantages of scientific research units in universities, and has established long-term collaboration with pharmaceutical research institutes, large domestic pharmaceutical units and enterprises around the world Relationship, our products has been exported to Europe, Japan, South Korea, North America and other countries.

      ShanLong Biotechnology is committed to product research, development, and production, and pushes continuously innovative products to the global market. The company has always adhered to the business values of "quality for stability, innovation for development", reliable reputation, first-class service, and flexibility Pursuing long-term goals, sincere cooperation, mutual benefit and common development with colleagues in the chemical and pharmaceutical industries.

Product Packaging and shipping